MILLER RICHARD A MD
Insider CIK 1031847 · CRVS President and CEO, Director · BOLT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRVS Corvus Pharmaceuticals, In | P Buy | 2026-05-18 | 2026-05-20 | 1,932 | $12.01 | $23.2K | 1,195,035 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2026-05-18 | 2026-05-20 | 5,000 | $12.05 | $60.3K | 1,193,103 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2025-12-04 | 2025-12-08 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | M Exercise deriv | 2025-05-07 | 2025-05-09 | 559,073 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | M Exercise | 2025-05-07 | 2025-05-09 | 559,073 | $3.50 | $1.96M | 1,136,707 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2024-12-20 | 2024-12-23 | 750,000 | — | $0 | 750,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | G Gift | 2024-05-10 | 2024-05-14 | 302,016 | — | $0 | 1,188,103 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy deriv | 2024-05-06 | 2024-05-07 | 559,073 | — | $0 | 559,073 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2024-05-06 | 2024-05-07 | 577,634 | $1.73 | $999.3K | 577,634 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2023-12-06 | 2023-12-08 | 500,000 | — | $0 | 500,000 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2023-06-12 | 2023-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2023-03-31 | 2023-04-03 | 800,000 | — | $0 | 800,000 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2022-12-14 | 2022-12-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-12-14 | 2022-12-15 | 10,000 | $0.78 | $7.8K | 1,490,119 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-12-13 | 2022-12-15 | 50,000 | $0.74 | $37.0K | 1,480,119 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-09-28 | 2022-09-28 | 25,000 | $0.76 | $19.0K | 1,394,405 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-09-20 | 2022-09-20 | 12,300 | $0.81 | $10.0K | 1,361,705 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-09-20 | 2022-09-20 | 5,000 | $0.82 | $4.1K | 1,369,405 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-09-20 | 2022-09-20 | 2,700 | $0.82 | $2.2K | 1,364,405 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2022-08-11 | 2022-08-15 | 320,000 | — | $0 | 320,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-06-27 | 2022-06-28 | 5,000 | $1.00 | $5.0K | 1,349,405 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-06-24 | 2022-06-28 | 5,000 | $1.03 | $5.2K | 1,344,405 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2022-06-10 | 2022-06-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-06-06 | 2022-06-06 | 890 | $1.01 | $899 | 1,339,405 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-06-02 | 2022-06-06 | 170 | $0.97 | $165 | 1,338,515 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-06-02 | 2022-06-06 | 4,830 | $0.98 | $4.7K | 1,338,345 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-03-31 | 2022-04-01 | 15,000 | $1.64 | $24.6K | 1,333,515 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2022-03-24 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-03-17 | 2022-03-17 | 5,000 | $1.59 | $8.0K | 1,318,515 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2022-03-15 | 2022-03-17 | 25,000 | $1.47 | $36.8K | 1,313,515 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2021-09-09 | 2021-09-13 | 320,000 | — | $0 | 320,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2021-08-20 | 2021-08-23 | 10,000 | $1.93 | $19.3K | 1,288,515 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2021-05-04 | 2021-05-05 | 35,714 | $2.80 | $100.0K | 35,714 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2021-02-17 | 2021-02-17 | 100,000 | $3.50 | $350.0K | 1,278,515 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2020-12-16 | 2020-12-17 | 320,000 | — | $0 | 320,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2019-12-12 | 2019-12-16 | 320,000 | — | $0 | 320,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-11-13 | 2019-11-14 | 14,736 | $3.00 | $44.2K | 1,178,515 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-11-12 | 2019-11-14 | 272 | $2.90 | $789 | 1,163,779 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-08-07 | 2019-08-08 | 2,500 | $3.54 | $8.8K | 1,163,507 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-08-06 | 2019-08-08 | 5,000 | $3.58 | $17.9K | 1,161,007 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-06-14 | 2019-06-17 | 11,657 | $3.40 | $39.6K | 1,156,007 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-06-13 | 2019-06-17 | 343 | $3.52 | $1.2K | 1,144,350 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-06-11 | 2019-06-11 | 6,000 | $3.67 | $22.0K | 1,144,007 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-06-07 | 2019-06-11 | 9,212 | $3.37 | $31.0K | 1,138,007 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2018-12-27 | 2018-12-31 | 20,000 | $3.29 | $65.8K | 1,128,795 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2018-12-20 | 2018-12-26 | 5,000 | $4.40 | $22.0K | 1,103,795 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2018-12-20 | 2018-12-26 | 5,000 | $4.39 | $21.9K | 1,108,795 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2018-12-12 | 2018-12-14 | 250,000 | — | $0 | 250,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | G Gift | 2018-12-11 | 2018-12-14 | 10,000 | — | $0 | 1,098,795 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | G Gift | 2018-12-11 | 2018-12-14 | 10,000 | — | $0 | 1,108,795 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2018-12-06 | 2018-12-10 | 5,000 | $5.99 | $29.9K | 1,118,795 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2018-12-04 | 2018-12-06 | 1,502 | $5.95 | $8.9K | 1,113,795 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2018-03-12 | 2018-03-12 | 100,000 | $8.50 | $850.0K | 1,112,293 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2017-12-13 | 2017-12-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2017-11-20 | 2017-11-22 | 10,000 | $10.79 | $107.9K | 1,012,293 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2017-06-13 | 2017-06-13 | 2,500 | $9.75 | $24.4K | 999,793 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2017-06-13 | 2017-06-13 | 2,500 | $10.14 | $25.4K | 1,002,293 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2017-06-12 | 2017-06-13 | 11,216 | $9.82 | $110.1K | 997,293 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2017-06-09 | 2017-06-13 | 3,784 | $9.89 | $37.4K | 986,077 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2017-06-09 | 2017-06-13 | 5,000 | $9.95 | $49.8K | 982,293 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2016-12-07 | 2016-12-08 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-05-13 | 2016-05-16 | 300 | $9.94 | $3.0K | 1,077,293 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-05-12 | 2016-05-16 | 30,000 | $10.00 | $300.0K | 1,076,993 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion deriv | 2016-03-29 | 2016-03-29 | 62,455 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion deriv | 2016-03-29 | 2016-03-29 | 266,310 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion | 2016-03-29 | 2016-03-29 | 62,455 | — | $0 | 1,046,993 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | C Conversion | 2016-03-29 | 2016-03-29 | 266,310 | — | $0 | 984,538 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | A Award deriv | 2016-03-22 | 2016-03-24 | 500,000 | — | $0 | 500,000 | SEC↗ |